查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439640

神經血管栓塞裝置 - 全球市場考量、競爭格局、市場預測 (2030)

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球神經血管栓塞器械市場規模將於 2023 年達到 12.9 億美元，到 2030 年將達到 15.9 億美元，預計在 2024-2030 年預測期內複合年增長率為 3.50%。 神經血管栓塞裝置的需求增加主要是由於腦出血和血管異常的盛行率不斷增加，以及久坐生活方式導致的腦動脈瘤和動靜脈畸形（AVM）的增加。 此外，老年人口的增加、高血壓盛行率的增加、各種栓塞產品的推出等是全球神經血管栓塞器械市場的成長因素。

神經血管栓塞裝置的市場動態

由於人類出血和腦動脈瘤盛行率不斷上升，神經血管栓塞設備市場目前正在蓬勃發展。 根據公共衛生系統國民醫療服務體系(NHS) 的說法，有許多因素會增加腦動脈瘤的風險，包括吸菸、嚴重頭部外傷、濫用古柯鹼和血壓升高。這可能會導致腦動脈瘤風險增加。需求。 例如，根據世界衛生組織（WHO）2023年發佈的數據，全球約12.8億30歲至79歲的成年人患有高血壓。 數據也顯示，三分之二的高血壓患者生活在低收入和中等收入國家。

此外，老年人口的持續擴張也可能在未來幾年對神經血管栓塞器械市場做出貢獻。 腦動脈瘤在30歲至60歲之間的成年人更常見，且女性比男性更常見。 聯合國經濟和社會事務部人口司（UN DESA）發佈的《2020年世界人口老化要點》預計，2020年全球65歲以上人口將達7.27億人。 根據同一份報告，女性佔老年人尤其是老年人的大多數，到2020年，女性佔全球65歲及以上人口的55%。

此外，栓塞產品的核准也可能有助於市場成長。 例如，Terumo公司開發的囊內血流阻斷裝置Woven EndoBridge（WEB）動脈瘤栓塞系統於2019年獲得美國FDA核准。

因此，所有上述因素預計將在預測期內加強對神經血管栓塞設備的需求。

然而，與神經血管栓塞相關的某些併發症，例如微導管、微導絲、線圈等引起的動脈瘤穿孔，可能會抑制市場。

史無前例的 COVID-19 大流行正在減緩神經血管栓塞設備市場的發展。 這是由於一些國家正在實施封鎖、社會疏離規範和反傳播措施。 此外，除了停止手術、減少蛛網膜下腔出血 (SAH) 住院人數以及對破裂動脈瘤進行彈簧圈栓塞幹預以防止病毒傳播外，大多數重症監護病房 (ICU) 現已對 COVID-19 患者關閉。由於大量湧入導致的飽和，醫護人員對控制疫情的關注也影響了市場。

神經血管栓塞器械市場細分分析

在神經血管栓塞裝置產品類型領域，預計栓塞彈簧圈在預測期內將佔重要的市場佔有率。 這是由於栓塞線圈的廣泛使用以及製造商加大力度開發先進的栓塞線圈，這可能會提高患者群體中的設備採用率。 例如，2019 年 10 月 21 日，Shape Memory Medical 的 TrelliX 栓塞線圈系統獲得了 CE 標誌，該系統採用專有的形狀記憶聚合物 (SMP) 技術。

此外，2019年9月17日，沃比醫療推出了一種差異化藥物，用於顱內動脈瘤和其他神經血管異常（如動靜脈畸形和動靜脈瘺管）的血管內栓塞治療。我們獲得了CE標誌批准和FDA 510(k)許可。我們的栓塞線圈系統，Avenir 線圈系統。 該系統提供全系列的捲材，包括高度穩定的框架卷材、高容量的填充卷材和極其靈活的精加工卷材。

本報告研究和分析了全球神經血管栓塞器械市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章神經血管栓塞器械市場報告簡介

第 2 章神經血管栓塞器械市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理與專利分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章神經血管栓塞器材市場關鍵因素分析

  • 神經血管栓塞器械市場的驅動因素
    • 由於嚴重頭部外傷、久坐的生活方式等，神經血管疾病（如腦動脈瘤和出血）的盛行率增加。
    • 全球高血壓盛行率不斷上升
    • 世界各地的產品核准和上市量增加
    • 人口老化負擔日益加重
  • 神經血管栓塞器材市場的限制與挑戰
    • 與栓塞彈簧圈相關的併發症
    • 嚴格的監管審批
  • 神經血管栓塞器材市場機會
    • 中低收入地區的成長機會
    • 透過大公司之間的策略夥伴關係獲得成長機會

第5章神經血管栓塞裝置波特五力分析

第6章COVID-19對神經血管栓塞器材市場的影響分析

第7章神經血管栓塞器械市場佈局

  • 依產品類型
    • 栓塞線圈
    • 神經血管線圈輔助裝置
    • 液體栓塞系統
    • 血流調節支架
    • 囊內血流阻斷裝置
    • 其他
  • 按最終用戶
    • 醫院
    • 門診手術中心
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章神經血管栓塞裝置：全球公司佔有率分析 - 3 至 5 家主要公司

第9章神經血管栓塞器械公司及產品簡介

  • Medtronic
  • Stryker
  • MicroVention, Inc. (Terumo Corporation)
  • Johnson & Johnson Services, Inc.
  • Penumbra, Inc.
  • Balt
  • B. Braun Melsungen AG
  • Acandis GmbH
  • Wallaby Medical
  • Shape Memory Medical Inc.
  • Zylox-Tonbridge Medical Technology Co., Ltd.
  • Spartan Micro, Inc.
  • KANEKA CORPORATION
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • Boston Scientific Corporation
  • phenox GmbH
  • Merit Medical Systems
  • Perflow Medical Ltd
  • MicroPort Scientific Corporation.
  • Cerus Endovascular
  • Rapid Medical

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡資訊

Product Code: DIMDCL0477

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents And Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), by geography, is expected to expand at a static CAGR forecast till 2030 due to the rising cases of hemorrhages and brain aneurysm in the population across the globe and launch of embolization products in different regions worldwide

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030. The rise in the demand for neurovascular embolization devices is predominantly attributed to the increasing prevalence of hemorrhages and the abnormalities in blood vessels present in the brain, increasing brain aneurysms and arteriovenous malformations (AVMs) due to sedentary lifestyles. Moreover, the rise in the geriatric population, increasing prevalence of high blood pressure, the launch of various embolization products, among others are the factors responsible for the global neurovascular embolization devices market growth.

Neurovascular Embolization Devices Market Dynamics:

The market for neurovascular embolization devices is gaining momentum at present owing to the rise in prevalence of hemorrhages and brain aneurysms among the population. According to the National Health Service (NHS), a publicly funded healthcare system, there are a lot of factors such as smoking, severe head injury, cocaine abuse, increase in blood pressure, among others that increases the risk of developing brain aneurysm among the population, thus would lead to an increase in the demand for neurovascular embolization devices. For instance, according to the data published by the World Health Organization (WHO) in the year 2023, approximately 1.28 billion adults aged between 30-79 years have hypertension across the globe. Also, the data mentioned that two-third of the population suffering from hypertension are living in low- and middle-income countries.

Furthermore, the ongoing expansion of the geriatric population would also contribute to the neurovascular embolization devices market in the forthcoming years. This is because brain aneurysm is common in adults between the ages of 30 and 60 and are more common in women than in men. According to the World Population Ageing 2020 Highlights published by the Population Division of the United Nations Department of Economic and Social Affairs (UN DESA), there were an estimated 727 million persons aged 65 years and above across the globe in the year 2020. As per the same report, women comprised of a majority of the older person, especially at an advanced age, and accounted for 55% of the global population aged 65 years and over in the year 2020.

In addition, approval of embolization products would also contribute to market growth. For instance, Woven EndoBridge (WEB) Aneurysm Embolization System, an Intrasaccular Flow Disruption Device developed by Terumo Corporation was approved by the US FDA in the year 2019.

Hence, all the aforementioned factors are anticipated to bolster the demand for neurovascular embolization devices during the forecasted period.

However, certain complications associated with the neurovascular embolization procedures such as procedural aneurysmal perforations by the microcatheter, micro-guidewire, or coil, among others are likely to impede the market.

The unprecedented COVID-19 pandemic has slowed down the market for neurovascular embolization devices. This is owing to the implementation of lockdown, the social distancing norms, and containment measures in several countries. Moreover, halt in surgeries, decreased volumes in subarachnoid hemorrhage (SAH) hospitalizations, and ruptured aneurysm coiling interventions to prevent the transmission of the virus, shifting focus of healthcare professionals to manage the pandemic as most of the intensive care units (ICU) were saturated with the massive influx of COVID-19 patients, among others also affected the market.

Neurovascular Embolization Devices Market Segment Analysis:

Neurovascular Embolization Devices Market By Product Type (Embolization Coils, Neurovascular Coil Assist Devices [Coil Assist Stents and Coil Assist Balloons], Liquid Embolization Systems, Flow Diversion Stents, Intrasaccular Flow Disruptor, Others), By End-User (Hospitals, Ambulatory Surgical Centers), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Neurovascular Embolization Devices product type segment, the embolization coil is anticipated to hold a significant market share during the forecasted period. This is due to the wide availability of embolization coils and growing initiatives by the manufacturers to develop advanced embolization coils which in turn would increase the adoption rate of the devices among the patient population. For instance, on October 21, 2019, Shape Memory Medical received CE Mark for the TrelliX® Embolic Coil System which features proprietary shape memory polymer (SMP) technology.

Also, on September 17, 2019, Wallaby Medical received CE Mark approval and FDA 510(k) clearance for its differentiated embolic coil system, the Avenir Coil System intended to use for endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae. The system offers a full line of coils including exceptional stable framing coils, extra volume filling coils, and ultra-soft finishing coils.

In addition, companies raising funds for the development and commercialization of neurovascular embolic coils are also expected to contribute to the segmental growth of the neurovascular embolization devices market. For instance, in July 2022, Zylox-Tonbridge Medical Technology Co., Ltd., a neuro- and peripheral-vascular interventional medical device company raised USD 329 million to support the development and commercialization of its core products which include neurovascular embolization coils, a micro catheter for coiling, among others.

Thus, all the above-mentioned factors would boost the market for neurovascular embolization devices in the upcoming years.

North America is expected to dominate the overall Neurovascular Embolization Devices Market:

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

For instance, as per the 2022 data of the Brain Aneurysm Foundation, an estimated 6.5 million people in the US have an unruptured brain aneurysm in the year 2020 and about 30,000 people suffer from a brain aneurysm rupture each year.

In addition, an increase in government initiatives and funding to support research for brain aneurysms in the country would also increase the regional market for neurovascular embolization devices. For instance, as per the bill presented in the 117 session on March 03, 2022, USD 10,000,000 has been funded by the government to conduct or support further comprehensive research on unruptured intracranial aneurysms for each of fiscal years 2022 through 2028 which will remain available through September 30, 2029.

Moreover, strategic business activities and approval of products in the region would also boost the regional market for neurovascular embolization devices. For instance, in the year 2020, Kaneka Corporation received FDA approval for its new brain aneurysm Embolization coil, i-ED COIL(TM).

Hence, the interplay of all the aforementioned factors will bolster the demand for the neurovascular embolization market in the region during the forecasted period.

Furthermore, the Asia-pacific region has future potential for the neurovascular embolization devices market. This is owing to the rising sedentary lifestyle such as consumption of alcohol, increase in aging population, growing head injuries, among others. For instance, as per the World Bank Group 2022 data, in the year 2020, China had 168,863,853 population aged 65 and above.

In addition, strategic business activity to expand the domestic market in the APAC region would also contribute to the neurovascular embolization devices market. For instance, in the year 2020, Genesis MedTech Group acquired Minitech Medical, a leading domestic enterprise in the neurovascular industry, and successfully developed and launched its first domestically-made intracranial embolization stent. Hence, all of these factors are likely to make APAC the fastest market for neurovascular embolization devices during the forecasted period.

Neurovascular Embolization Devices Market Key Players:

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

Recent Developmental Activities in the Neurovascular Embolization Devices Market:

In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. ("MicroPort® NeuroTech") received the registration certificates issued by China's National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.

In April 2020, Cerus Endovascular received CE Mark approval for its Neqstent Coil Assisted Flow Diverter device designed for the treatment of intracranial aneurysms.

In May 2019, Rapid Medical, a company focused on the development of next-generation neurovascular devices, received FDA clearance for the Comaneci device as a temporary coil embolization assist device.

Key Takeaways from the Neurovascular Embolization Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Neurovascular Embolization Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Neurovascular Embolization Devices Market.

Various opportunities available for the other competitor in the Neurovascular Embolization Devices Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Neurovascular Embolization Devices market growth in the coming future?

Target Audience who can be benefited from the Neurovascular Embolization Devices Market Report Study

Neurovascular Embolization Devices providers

Research organizations and consulting companies

Neurovascular Embolization Devices-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Neurovascular Embolization Devices

Various End-users who want to know more about the Neurovascular Embolization Devices Market and latest technological developments in the Neurovascular Embolization Devices market.

Frequently Asked Questions for the Neurovascular Embolization Devices Market:

1. What are Neurovascular Embolization Devices?

A neurovascular embolization device is an intravascular implant intended to permanently occlude blood flow to cerebral aneurysms and cerebral arteriovenous malformations.

2. What is the market for Global Neurovascular Embolization Devices?

The global neurovascular embolization devices market was valued at USD 1.29 billion in 2023, growing at a CAGR of 3.50% during the forecast period from 2024 to 2030, to reach USD 1.59 billion by 2030.

3. What are the drivers for the Global Neurovascular Embolization Devices?

The major factors driving the demand for Neurovascular Embolization Devices are the rising cases of hemorrhage stroke, brain aneurysm, and cerebral arteriovenous malformations due to sedentary lifestyles such as excessive consumption of alcohol, serious head injuries, and others. In addition, the rising prevalence of high blood pressure, growing product approval, and increase in the aging population, among others are also expected to boost the market.

4. What are the key players operating in Global Neurovascular Embolization Devices?

Some of the key market players operating in the Neurovascular Embolization Devices market include Medtronic, Stryker, MicroVention, Inc. (Terumo Corporation), Johnson & Johnson Services, Inc., Penumbra, Inc., Balt, B. Braun Melsungen AG, Acandis GmbH, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., KANEKA CORPORATION, Lepu Medical Technology(Beijing)Co., Ltd., Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, phenox GmbH, Merit Medical Systems., Perflow Medical Ltd., MicroPort Scientific Corporation., Cerus Endovascular, Rapid Medical, among others.

5. Which region has the highest share in the Neurovascular Embolization Devices market?

Among all the regions, North America is expected to occupy a major share in the overall neurovascular embolization devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of key market players and the recent launch of embolization products in the region is anticipated to propel the neurovascular embolization market.

Table of Contents

1.Neurovascular Embolization Devices Market Report Introduction

2.Neurovascular Embolization Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Neurovascular Embolization Devices Market Key factors analysis

  • 4.1 Neurovascular Embolization Devices Market Drivers
    • 4.1.1 Growing prevalence of neurovascular disorders such as brain aneurysm, hemorrhage, and others due to severe head injuries, sedentary lifestyle, others
    • 4.1.2 Increase in prevalence of hypertension across the globe
    • 4.1.3 Increasing product approval & launches across the globe
    • 4.1.4 The growing burden of the geriatric population
  • 4.2 Neurovascular Embolization Devices Market Restraints and Challenges
    • 4.2.1 Complications associated with embolization coils
    • 4.2.2 Stringent regulatory approvals
  • 4.3 Neurovascular Embolization Devices Market Opportunities
    • 4.3.1 Growth opportunities in low and middle-income regions
    • 4.3.2 Growth opportunities due to strategic partnership among key players

5. Neurovascular Embolization Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Neurovascular Embolization Devices Market

7. Neurovascular Embolization Devices Market layout

  • 7.1 By Product Type
    • 7.1.1 Embolization Coils
    • 7.1.2 Neurovascular Coil Assist Devices
      • 7.1.2.1 Coil Assist Stents
      • 7.1.2.2 Coil Assist Balloons
    • 7.1.3 Liquid Embolization Systems
    • 7.1.4 Flow diversion stents
    • 7.1.5 Intrasaccular flow disruptor
    • 7.1.6 Others
  • 7.2 By End-user
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 North America Neurovascular Embolization Devices Market, by Product Type
      • 7.3.1.2 North America Neurovascular Embolization Devices Market, by End User
      • 7.3.1.3 North America Neurovascular Embolization Devices Market, by Country
      • 7.3.1.3.1 United States
      • 7.3.1.3.2 Canada
      • 7.3.1.3.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 Europe Neurovascular Embolization Devices Market, by Product Type
      • 7.3.2.2 Europe Neurovascular Embolization Devices Market, by End User
      • 7.3.2.3 Europe Neurovascular Embolization Devices Market, by Country
      • 7.3.2.3.1 France
      • 7.3.2.3.2 Germany
      • 7.3.2.3.3 United Kingdom
      • 7.3.2.3.4 Italy
      • 7.3.2.3.5 Spain
      • 7.3.2.3.6 Russia
      • 7.3.2.3.7 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 Asia-Pacific Neurovascular Embolization Devices Market, by Product Type
      • 7.3.3.2 Asia-Pacific Neurovascular Embolization Devices Market, by End User
      • 7.3.3.3 Asia-Pacific Neurovascular Embolization Devices Market, by Country
      • 7.3.3.3.1 China
      • 7.3.3.3.2 Japan
      • 7.3.3.3.3 India
      • 7.3.3.3.4 Australia
      • 7.3.3.3.5 South Korea
      • 7.3.3.3.6 Rest of Asia Pacific
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 RoW Neurovascular Embolization Devices Market, by Product Type
      • 7.3.4.2 RoW Neurovascular Embolization Devices Market, by End User
      • 7.3.4.3 RoW Neurovascular Embolization Devices Market, by Region
      • 7.3.4.3.1 Middle East
      • 7.3.4.3.2 Africa
      • 7.3.4.3.3 South America

8. Neurovascular Embolization Devices Global Company Share Analysis - Key 3-5 Companies

9. Neurovascular Embolization Devices Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Stryker
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 MicroVention, Inc. (Terumo Corporation)
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Johnson & Johnson Services, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Penumbra, Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Balt
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 B. Braun Melsungen AG
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Acandis GmbH
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Wallaby Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Shape Memory Medical Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Zylox-Tonbridge Medical Technology Co., Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Spartan Micro, Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 KANEKA CORPORATION
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Lepu Medical Technology (Beijing) Co., Ltd.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 Meril Life Sciences Pvt. Ltd.
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Boston Scientific Corporation
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 phenox GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Merit Medical Systems
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Perflow Medical Ltd
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 MicroPort Scientific Corporation.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy
  • 9.21 Cerus Endovascular
    • 9.21.1. Company Overview
    • 9.21.2. Company Snapshot
    • 9.21.3. Financial Overview
    • 9.21.4 Product Listing
    • 9.21.5. Entropy
  • 9.22 Rapid Medical
    • 9.22.1. Company Overview
    • 9.22.2. Company Snapshot
    • 9.22.3. Financial Overview
    • 9.22.4 Product Listing
    • 9.22.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Table 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Table 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Table 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Table 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Table 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Table 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Table 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Table 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Table 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Table 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Table 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Table 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Table 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Table 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Table 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Table 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Table 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Table 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Table 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Table 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Table 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Table 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Table 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Table 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Table 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Table 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Table 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Table 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Table 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Neurovascular Embolization Devices Market
  • Figure 3 Neurovascular Embolization Devices Market Analysis in Global (2021-2030)
  • Figure 4 Neurovascular Embolization Devices Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Neurovascular Embolization Devices Market Analysis in Global by End User (2021-2030)
  • Figure 6 Neurovascular Embolization Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 7 Neurovascular Embolization Devices Market Analysis in North America (2021-2030)
  • Figure 8 Neurovascular Embolization Devices Market Analysis in North America by Product Type (2021-2030)
  • Figure 9 Neurovascular Embolization Devices Market Analysis in North America by End User (2021-2030)
  • Figure 10 Neurovascular Embolization Devices Market Analysis in North America by Country (2021-2030)
  • Figure 11 Neurovascular Embolization Devices Market Analysis in the US (2021-2030)
  • Figure 12 Neurovascular Embolization Devices Market Analysis in Canada (2021-2030)
  • Figure 13 Neurovascular Embolization Devices Market Analysis in Mexico (2021-2030)
  • Figure 14 Neurovascular Embolization Devices Market Analysis in Europe (2021-2030)
  • Figure 15 Neurovascular Embolization Devices Market Analysis in Europe by Product Type (2021-2030)
  • Figure 16 Neurovascular Embolization Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 17 Neurovascular Embolization Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 18 Neurovascular Embolization Devices Market Analysis in France (2021-2030)
  • Figure 19 Neurovascular Embolization Devices Market Analysis in Germany (2021-2030)
  • Figure 20 Neurovascular Embolization Devices Market Analysis in the UK (2021-2030)
  • Figure 21 Neurovascular Embolization Devices Market Analysis in Italy (2021-2030)
  • Figure 22 Neurovascular Embolization Devices Market Analysis in Spain (2021-2030)
  • Figure 23 Neurovascular Embolization Devices Market Analysis in Russia (2021-2030)
  • Figure 24 Neurovascular Embolization Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 25 Neurovascular Embolization Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 26 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 27 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 28 Neurovascular Embolization Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 29 Neurovascular Embolization Devices Market Analysis in China (2021-2030)
  • Figure 30 Neurovascular Embolization Devices Market Analysis in Japan (2021-2030)
  • Figure 31 Neurovascular Embolization Devices Market Analysis in India (2021-2030)
  • Figure 32 Neurovascular Embolization Devices Market Analysis in Australia (2021-2030)
  • Figure 33 Neurovascular Embolization Devices Market Analysis in South Korea (2021-2030)
  • Figure 34 Neurovascular Embolization Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 35 Neurovascular Embolization Devices Market Analysis in Rest of World (2021-2030)
  • Figure 36 Neurovascular Embolization Devices Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 37 Neurovascular Embolization Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 38 Neurovascular Embolization Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 39 Neurovascular Embolization Devices Market Analysis in the Middle East (2021-2030)
  • Figure 40 Neurovascular Embolization Devices Market Analysis in Africa (2021-2030)
  • Figure 41 Neurovascular Embolization Devices Market Analysis in South America (2021-2030)
  • Figure 42 Market Drivers
  • Figure 43 Market Barriers
  • Figure 44 Market Opportunities
  • Figure 45 PORTER's Five Force Analysis